We concluded that hyperandrogenemia lowered insulin sensitivity if there was a previous prenatal exposure to testosterone excess, but also that prenatal exposure to testosterone, regardless of the presence of hyperandrogenemia, decreased glucose-induced secretion of insulin which is consistent with pancreatic reprogramming. The gene discussed is INS; the disease is polycystic ovary syndrome.